Metastatic Colorectal Cancers Completed Phase 2 Trials for Ganitumab (DB12205)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00891930Study to Evaluate Mechanisms of Acquired Resistance to PanitumumabTreatment